| Lawrence J Horn, MD | |
|
Rehabilitation Institute Of Michigan, 261 Mack Blvd, Detroit, MI 48201 | |
| (313) 745-4600 | |
| (313) 745-1063 |
| Full Name | Lawrence J Horn |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine & Rehabilitation |
| Location | Rehabilitation Institute Of Michigan, Detroit, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942240817 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | MD2018-0791 (New Mexico) | Secondary |
| 208100000X | Physical Medicine & Rehabilitation | 4301085039 (Michigan) | Primary |
| Entity Name | Unm Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831218627 PECOS PAC ID: 4981795267 Enrollment ID: O20070801000589 |
News Archive
CoAxia Inc. of Maple Grove, MN, announced today that the results of the SENTIS clinical trial a worldwide, multi-center, randomized study of its NeuroFlo catheter were presented on Saturday, October 16th, by SENTIS Principal Investigator, Professor Ashfaq Shuaib at the 2010 World Stroke Congress in Seoul, South Korea.
Intellipharmaceutics International Inc. today announced that Novartis Pharmaceuticals Corporation and Celgene Corporation have settled their patent suit in the U.S. District Court for the District of New Jersey, and Elan Pharma International Ltd. has settled its patent suit in the U.S. District Court for the District of Delaware, with Intellipharmaceutics Corp., a wholly-owned subsidiary of Intellipharmaceutics International, and its licensee Par Pharmaceutical, Inc. over a generic version of the Attention Deficit Hyperactivity Disorder drug Focalin XR® (dexmethylphenidate hydrochloride).
A new study suggests that resistance exercise may improve indicators of type 2 diabetes by increasing expression of a protein that regulates blood sugar (glucose) absorption in the body.
Welichem today announced that the Company has begun to enroll patients in a Phase IIb clinical trial with its lead candidate, WBI-1001. The Phase IIb clinical trial is a double-blinded, placebo-controlled, 12-week-treatment study.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lawrence J Horn, MD 1560 E Maple Rd, Suite 400-credentialing, Troy, MI 48083-1138 Ph: (313) 745-4600 | Lawrence J Horn, MD Rehabilitation Institute Of Michigan, 261 Mack Blvd, Detroit, MI 48201 Ph: (313) 745-4600 |
News Archive
CoAxia Inc. of Maple Grove, MN, announced today that the results of the SENTIS clinical trial a worldwide, multi-center, randomized study of its NeuroFlo catheter were presented on Saturday, October 16th, by SENTIS Principal Investigator, Professor Ashfaq Shuaib at the 2010 World Stroke Congress in Seoul, South Korea.
Intellipharmaceutics International Inc. today announced that Novartis Pharmaceuticals Corporation and Celgene Corporation have settled their patent suit in the U.S. District Court for the District of New Jersey, and Elan Pharma International Ltd. has settled its patent suit in the U.S. District Court for the District of Delaware, with Intellipharmaceutics Corp., a wholly-owned subsidiary of Intellipharmaceutics International, and its licensee Par Pharmaceutical, Inc. over a generic version of the Attention Deficit Hyperactivity Disorder drug Focalin XR® (dexmethylphenidate hydrochloride).
A new study suggests that resistance exercise may improve indicators of type 2 diabetes by increasing expression of a protein that regulates blood sugar (glucose) absorption in the body.
Welichem today announced that the Company has begun to enroll patients in a Phase IIb clinical trial with its lead candidate, WBI-1001. The Phase IIb clinical trial is a double-blinded, placebo-controlled, 12-week-treatment study.
› Verified 1 days ago
Monica Marie Loving, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 4646 John R St, Detroit, MI 48201 Phone: 313-576-1000 | |
Dr. Medha Shah, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 261 Mack Ave, Detroit, MI 48201 Phone: 313-745-2550 | |
Mr. Slawomir Edward Janiszewski, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 4646 John R St, Detroit, MI 48201 Phone: 313-576-3511 | |
Peter Hanna Gumma, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 17187 Schaefer Hwy, Detroit, MI 48235 Phone: 313-367-2767 Fax: 313-367-2818 | |
Dr. Matthew Thomas Santa Barbara, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2181 | |
Abulhasan Sayed, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 261 Mack Ave, Detroit, MI 48201 Phone: 313-745-9733 Fax: 313-745-1063 | |
Ali Ahmad Bitar, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: Rehabilitation Institute Of Michigan, 261 Mack Blvd, Detroit, MI 48201 Phone: 313-966-0544 Fax: 313-745-1065 |